Average Co-Inventor Count = 6.31
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Melbourne Health (9 from 24 patents)
2. Austin Health (8 from 13 patents)
3. Abl Sa (6 from 6 patents)
4. Southern Health (4 from 6 patents)
5. Central Sydney Area Health Service (2 from 11 patents)
6. Austin and Repatriation Medical Centre (2 from 2 patents)
7. St. Vincents Hospital (melbourne) Limited (1 from 5 patents)
8. Melbourne Health; St. Vincent's Hospital Melbourne; Austin Health (1 from 1 patent)
9. Melborne Health (1 from 1 patent)
10. Alfred Health (5 patents)
11. St. Vincent's Hospital (melbourne) Ltd. Trading As St. Vincent's Hospital Melbourne (0 patent)
17 patents:
1. 9932646 - Detection and use of antiviral resistance mutations
2. 9702005 - Hepatitis B viral variants with reduced susceptibility to nucleoside analogs and uses thereof
3. 9701982 - Variants of hepatitis B virus with resistance to anti-viral nucleoside agents and applications thereof
4. 9682109 - Antiviral resistance mutants and applications thereof
5. 8859198 - Detection and use of antiviral resistance mutations
6. 8592143 - Hepatitis B viral variants with reduced susceptibility to nucleoside analogs and uses thereof
7. 8367317 - Variants of hepatitis B virus with resistance to anti-viral nucleoside agents and applications thereof
8. 8211443 - Variants of hepatitis B virus with resistance to anti-viral nucleoside agents and applications thereof
9. 8211633 - Viral variants with altered susceptibility to nucleoside analogs and uses thereof
10. 7989162 - Viral variants with altered susceptibility to nucleoside analogs and uses thereof
11. 7931907 - Hepatitis B virus DNA polymerase and surface antigen variants and methods of using same
12. 7887813 - Variants of hepatitis B virus with resistance to anti-viral nucleoside agents and applications thereof
13. 7846663 - Hepatitis B viral variants with reduced susceptibility to nucleoside analogs and uses thereof
14. 7745130 - Hepatitis B viral variants with reduced susceptibility to nucleoside analogs and uses thereof
15. 7431933 - Hepatitis B virus DNA polymerase and surface antigen variants and methods of using same